As China embraces AI, only 24% of US pharma execs bet on it for drug-making
- Posted on September 9, 2026
- By South China Morning Post
- 0 Views
- 1 min read
In brief
Generating AI summary…
As China embraces AI, only 24% of US pharma execs bet on it for drug-making
Study finds 50 companies had fully, partially or planned to scale AI, tech which could slash drug discovery costs by US$26 billion globally.
